My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Teplizumab Biosimilar, CD3 Monoclonal Antibody

Teplizumab Biosimilar, CD3 Monoclonal Antibody

cluster of differentiation 3, CD3D, CD3E, CD3G

Catalog No. Product Name Size List Price (US$) Quantity
C056P Teplizumab Biosimilar, Human CD3e Monoclonal Antibody 1 mg 200.00
C056P Teplizumab Biosimilar, Human CD3e Monoclonal Antibody 5 mg 600.00
C056P Teplizumab Biosimilar, Human CD3e Monoclonal Antibody 20 mg 1200.00
Description

C056P: Teplizumab Biosimilar, CD3 Monoclonal Antibody

Recombinant human IgG1 Monoclonal Antibody. Muromonab is the parental mouse anti-CD3 mAb (OKT3 or OKT-3); teplizumab is the humanized version with the human IgG1 kappa constant regions and the Fc region having Fc receptor non-binding (FNB) properties.
Clone: OKT3 or OKT-3.
Isotype: Human IgG1 kappa.
Source: The anti-human CD3 monoclonal antibody teplizumab biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade teplizumab biosimilar specifically binds to the human T cell receptor CD3.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by teplizumab.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The research grade teplizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Background

Teplizumab biosimilar uses the same protein sequences as the therapeutic antibody teplizumab (humanized OKT3).

A fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex, teplizumab (humanized OKT-3) is used to delay the onset of stage 3 type 1 diabetes (T1D) in people with stage 2 T1D.

Syd Labs provides the following anti-human CD3 antibodies:
Muromonab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Teplizumab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Foralumab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Anti-human CD3 monoclonal antibody (Clone: OKT3)
Anti-human CD3 monoclonal antibody (Clone: SP34-2)
Anti-human CD3 monoclonal antibody (Clone: UCHT1)

Syd Labs provides the following anti-mouse CD3 antibodies:
Anti-mouse CD3e monoclonal antibody (Clone: 145-2C11)
Anti-mouse CD3e monoclonal antibody (Clone: 500A2)
Anti-mouse CD3 monoclonal antibody (Clone: 17A2)

Related Links

See our Privacy Policy